- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02044575
Clock Genes in Patients With Refractory Septic Shock (SeptiClock) - Pilot Study
Despite large efforts trying to improve diagnostic and therapy of sepsis have been made over the last decade (e.g. initiation of the Surviving Sepsis Campaign, defining evidence based sepsis therapy bundles) the mortality of septic shock remains high and causes high socioeconomical burden of disease.
The purpose of this pilot study is to evaluate the design and conduct of a projected full scale clinical trial.
Study Overview
Status
Conditions
Detailed Description
A functional clock is required for induction of several proinflammatory genes, not shown in septic patient settings, yet.
Clock genes are involved in modulating the activity of several transcription factors that are important regulators of immune functions (e.g. HIF1-α, STAT1, STAT3, and NF-κB) (Bellet MM et al., 2013).
Furthermore, polymorphisms such as rs7221412, a common polymorphism near period homolog 1 (PER1), was associated with the timing of activity rhythms and also showed a suggestive time-dependent relationship with both cerebral cortex and monocytes PER1 expression and an association with time of death (Lim ASP et al., 2012).
This explorative project is a pilot study. First data are generated for the assessment of the circadian system in patients with septic shock.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
-
Berlin, Germany, 13353
- Department of Anesthesiology and Intensive Care Medicine, Campus Charité Mitte and Campus Virchow - Klinikum, Charité- Universitätsmedizin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Male and female patients with age 18 years and above,
- Patient at intensive care units (8i, 9i and 1i at Charité - University Medicine Berlin , Campus Virchow- Klinikum),
- Septic shock (ACCP/SCCM (American College of Chest Physicians/Society of Critical Care Medicine) consensus definitions) AND Norepinephrine dosage of >0.3 μg/kg/min for at least 2 hours
Exclusion Criteria:
- Pregnant or lactating female patient,
- Participation in another interventional study (30 days before study inclusion and during study participation),
- Acute leucemia,
- Severe leukocytosis (>50,000/nl),
- Severe thrombocytopenia (<5,000/nl),
- Autoimmune disease with systemic medication of ≥10 mg prednisolone equivalent or previous transplantation,
- Patients receiving interferon therapy (last 14 days),
- Patients with known hypersensitivity GM-CSF or known antibodies against GM-CSF, yeast-derived products or any component of the study medication,
- Ongoing (concomitant) chemotherapy or radiotherapy for malignancy,
- Acute pulmonary embolism or acute myocardial infarction within last 72 hours,
- Cardiopulmonary resuscitation within last 7 days,
- Moribund patient (life expectancy <72 hrs.),
- Presence of a do-not-resuscitate or do-not-intubate order,
- Known human immunodeficiency virus (HIV) infection or chronic viral hepatitis
- Lacking willingness to save and hand out data within the study
- Accommodation in an institution due to an official or judicial order
- The informed consent of the patient or the subject's legally acceptable representative can´t be obtained in time
- Patient has a power of attorney or patient's provision, where he/she refuses participation in any clinical trial
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Critically ill patients
Intensive care unit patients with refractory septic shock
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of circadian regulation
Time Frame: These parameters are measured during intensive care unit stay, for a maximum of 3 days
|
Circadian regulation by expression of clock genes
|
These parameters are measured during intensive care unit stay, for a maximum of 3 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Time on mechanical ventilation
Time Frame: They are followed up until the end of intensive care unit stay - or, for a maximum of 28 days
|
They are followed up until the end of intensive care unit stay - or, for a maximum of 28 days
|
|
Intensive care unit length of stay
Time Frame: Participants will be followed for the duration of intensive care stay, an expected average of 4 weeks
|
Participants will be followed for the duration of intensive care stay, an expected average of 4 weeks
|
|
Hospital length of stay
Time Frame: Participants will be followed for the duration of intensive care stay, an expected average of 5 weeks
|
Participants will be followed for the duration of intensive care stay, an expected average of 5 weeks
|
|
Simplified Acute Physiology Score (SOFA II)
Time Frame: They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.
|
They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.
|
|
Sequential Organ Failure Assessment (SOFA)
Time Frame: They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.
|
They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.
|
|
Therapeutic Intervention Scoring System (TISS-28)
Time Frame: They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.
|
They are measured until the end of intensive care unit stay - or, for a maximum of 28 days.
|
|
Mortality
Time Frame: 6 months after intensive care unit discharge
|
6 months after intensive care unit discharge
|
|
Light frequencies
Time Frame: Light frequencies are measured until the end of intensive care unit stay - or, for a maximum of 28 days
|
Light frequencies are measured until the end of intensive care unit stay - or, for a maximum of 28 days
|
|
Light levels (lux)
Time Frame: Light levels are measured until the end of intensive care unit stay - or, for a maximum of 28 days
|
Light levels are measured until the end of intensive care unit stay - or, for a maximum of 28 days
|
|
Cortisol
Time Frame: This parameter is measured in ng/ml during intensive care unit stay, for a maximum of 3 days
|
This parameter is measured in ng/ml during intensive care unit stay, for a maximum of 3 days
|
|
Melatonin
Time Frame: This parameter is measured in pg/ml during intensive care unit stay, for a maximum of 3 days
|
This parameter is measured in pg/ml during intensive care unit stay, for a maximum of 3 days
|
|
Quality of life
Time Frame: Up to 3 and 6 months
|
Quality of life is measured by SF-36 questionnaire
|
Up to 3 and 6 months
|
Cognitive function
Time Frame: Up to 3 and 6 months
|
Cognitive function is measured by Repeatable Battery for the Assessment of Neuropsychological Status
|
Up to 3 and 6 months
|
Multiplex-Genexpression analysis
Time Frame: These parameters are measured during intensive care unit stay, for a maximum of 3 days
|
Ncounter neuroinflammation and micro rna panel are analysed
|
These parameters are measured during intensive care unit stay, for a maximum of 3 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Nagalase enzyme activity
Time Frame: This parameter is measured at the beginning of the investigation
|
Nagalase Enzyme activity is expressed in nmol/min per Milliliter.
Analysis is evaluated with the perioperative Nagalase results of 10 patients in the clinical trial Phydelio (EudraCT-No 2008-007237-47).
|
This parameter is measured at the beginning of the investigation
|
Venous return
Time Frame: This parameter is measured at the beginning of the investigation
|
Venous return will be assessed after ICU admission by venous return pressure gradient (dVR)
|
This parameter is measured at the beginning of the investigation
|
Collaborators and Investigators
Sponsor
Publications and helpful links
General Publications
- Bellet MM, Deriu E, Liu JZ, Grimaldi B, Blaschitz C, Zeller M, Edwards RA, Sahar S, Dandekar S, Baldi P, George MD, Raffatellu M, Sassone-Corsi P. Circadian clock regulates the host response to Salmonella. Proc Natl Acad Sci U S A. 2013 Jun 11;110(24):9897-902. doi: 10.1073/pnas.1120636110. Epub 2013 May 28.
- Lim AS, Chang AM, Shulman JM, Raj T, Chibnik LB, Cain SW, Rothamel K, Benoist C, Myers AJ, Czeisler CA, Buchman AS, Bennett DA, Duffy JF, Saper CB, De Jager PL. A common polymorphism near PER1 and the timing of human behavioral rhythms. Ann Neurol. 2012 Sep;72(3):324-34. doi: 10.1002/ana.23636.
- Lachmann G, Ananthasubramaniam B, Wunsch VA, Scherfig LM, von Haefen C, Knaak C, Edel A, Ehlen L, Koller B, Goldmann A, Herzel H, Kramer A, Spies C. Circadian rhythms in septic shock patients. Ann Intensive Care. 2021 Apr 26;11(1):64. doi: 10.1186/s13613-021-00833-5.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SeptiClock
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Septic Shock
-
German Center for Neurodegenerative Diseases (DZNE)University Hospital, BonnUnknownSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockGermany
-
University Medicine GreifswaldUnknownSepsis Septic ShockGermany
-
McMaster UniversityCanadian Institutes of Health Research (CIHR); The Physicians' Services Incorporated...Recruiting
-
Assistance Publique - Hôpitaux de ParisCompletedSeptic Shock HyperdynamicFrance
-
Indonesia UniversityCompletedSevere Sepsis With Septic Shock | Severe Sepsis Without Septic ShockIndonesia
-
Centre Hospitalier Universitaire DijonCompleted
-
Mansoura UniversityUnknown
-
National Taiwan University HospitalBaxter Healthcare CorporationRecruiting
-
Charite University, Berlin, GermanyCompleted
-
University of ZurichCompletedPatients in Septic ShockSwitzerland